BPC-157 + TB-500 Combined · BC10 · Healing Stack Premix
A combined premix of BPC-157 and TB-500 — the two most widely researched healing peptides — in a single vial. BPC-157 provides localised tissue repair and nerve regeneration while TB-500 provides systemic reach and angiogenesis. Together they address both the local repair process and the systemic vascular support needed for comprehensive healing.
The BPC + TB premix combines BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4 analogue) in a single vial — the two most researched and complementary healing peptides available. Sourcing them as a premix simplifies the protocol to a single injection rather than two, with identical outcomes to separate administration.
BPC-157 is a 15 amino acid peptide isolated from human gastric juice with over 36 published studies demonstrating healing across musculoskeletal, gastrointestinal and neurological tissue. Its primary mechanisms include fibroblast migration acceleration, growth factor upregulation (VEGFR2), angiogenesis at injury sites and anti-inflammatory cytokine reduction. BPC-157 heals without scar tissue formation — a significant advantage over natural healing — and has specific data for nerve regeneration and neuroprotection.
TB-500 (Thymosin Beta-4 analogue) distributes systemically throughout the body, promoting cell migration, angiogenesis and stem cell recruitment to injury sites. Unlike BPC-157's primarily local action, TB-500 can reach multiple injury sites simultaneously through systemic circulation. It upregulates actin — the cell-building protein essential for tissue repair — and promotes stem cell differentiation into tissue-specific cells at repair sites.
The combination addresses all major phases of tissue repair simultaneously. BPC-157 drives the local cellular repair process — fibroblasts, collagen synthesis, growth factor signalling. TB-500 ensures systemic delivery of healing cells and blood supply to the injury site. Research in knee pain demonstrated an 87.5% positive response rate with the combination — higher than either compound produced alone in comparable cohorts.
The BPC+TB premix is applicable across a wide range of injury and healing contexts: acute muscle, tendon and ligament injuries; chronic tendinopathy; post-surgical recovery; spinal disc conditions; nerve compression and injury; gut mucosal damage; and general recovery optimisation in training athletes. The systemic reach of TB-500 makes the premix particularly valuable for multiple simultaneous injury sites.